Please Wait.....
Report
South & Central America Pharma ADMET Testing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Testing Type (In Vivo ADMET Testing, In Vitro ADMET Testing, and In Silico ADMET Testing), Technology (Cell Culture, High Throughput, Molecular Imaging, and OMICS Technology), and Application (Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity, and Others)
Market Report I 2022-10-07 I 114 Pages I The Insight Partners
The pharma ADMET testing market in South & Central America is expected to grow from US$ 386.47 million in 2022 to US$ 670.52 million by 2028. It is estimated to grow at a CAGR of 9.6% from 2022 to 2028.
Companies in the pharmaceuticals and biotechnology industries focus on the expansion of their research & development capabilities and drug manufacturing capacity. Rapid developments in computational software and the introduction of novel field technologies are estimated to raise the efficiency of drug development during the forecast period. For instance, toxicity, cytochrome p450 induction, and in vitro metabolism assays, among others, are being incorporated into a single assay on liver hepatocytes.
Similarly, 3D cell culture models with multiple tissue cell types are emerging as promising systems. Moreover, microfluidic organ-on-a-chip approaches, such as those commercialized by Emulate, are becoming more mainstream for predictive ADMET studies. ADMET Predictor by Simulations Plus, Inc., ADME/Tox by Sigma-Aldrich, LLC., PhysChem and ADME-Tox Prediction by ACD/Labs, PK/PD Database for Pharmacokinetic Properties by the Laboratory of Computational and Medicinal Chemistry, etc., are several tools developed for predicting toxicity related to ADME. Artificial intelligence (AI) may be used to simulate the ADME of drugs, determine if a therapeutic molecule will be effective in humans, and predict safety concerns.
During post-COVID recovery, the current popularity and concurrent emergence of AI and machine learning (ML) are likely to have a substantial impact on drug design and development. These technologies have decreased the need for human intervention and raised the quality of life of people as they can be implemented in designing superior-quality healthcare goods. With the help of specialized molecular modeling techniques, such as in-silico simulation, pharmacophore modeling, molecular dynamics, virtual screening, and molecular docking, AI&ML-driven rational drug design seeks to explain the unforeseen bioactivity of natural products most perfectly in a limited timeframe. Additionally, it describes the molecular interaction of drugs and their targets to create more effective drug leads. In January 2022, Charles River Laboratories and Valo Health, LLC, a technology firm leveraging human-centric data and AL-based computing, established a multi-year strategic collaboration to change the drug research & development process. A new revolutionary, AI-enabled drug discovery and development platform will be made available through this partnership by using Charles River's discovery optimization capabilities-including medicinal chemistry, ADME, biology, and pharmacology-and Valo's Opal Platform for small molecule development, which utilizes a "closed-loop" in a silico-experimental platform that rapidly iterates using program data to identify novel compounds. Thus, ADME testing based on automation, AI, and ML, among other technologies, is becoming an important part of the digital health boom, which is providing significant growth opportunities for the pharma ADMET testing market .
South & Central America Pharma ADMET Testing Market Revenue and Forecast to 2028 (US$ Million)
South & Central America Pharma ADMET Testing Market Segmentation
The South & Central America pharma ADMET testing market is segmented by testing type, technology, application, and country. Based on testing type, the South & Central America pharma ADMET testing market is segmented into in vivo ADMET testing, in vitro ADMET testing, and in silico ADMET testing. The in vivo ADMET testing segment dominated the market in 2022. Based on technology, the South & Central America pharma ADMET testing market is segmented into cell culture, high throughput, molecular imaging, and OMICS technology. The cell culture segment dominated the market in 2022. Based on application, the South & Central America pharma ADMET testing market is segmented into systemic toxicity, renal toxicity, hepatotoxicity, neurotoxicity, and others. The systemic toxicity segment dominated the market in 2022. Based on country, the South & Central America pharma ADMET testing market is segmented into Brazil, Argentina, and the rest of South & Central America. Further, Brazil dominated the market in 2022.
Some key players dominating the South & Central America pharma ADMET testing market are Agilent Technologies, Inc.; Bio-Rad Laboratories, Inc.; Biovia (Dassault Systemes); Charles River Laboratories; IQVIA Inc.; MERCK KGaA; and Promega Corporation.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 South & Central America Pharma ADMET Testing Market - By Testing Type
1.3.2 South & Central America Pharma ADMET Testing Market - By Technology
1.3.3 South & Central America Pharma ADMET Testing Market - By Application
1.3.4 South & Central America Pharma ADMET Testing Market - By Country
2. South & Central America Pharma ADMET Testing Market- Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Pharma ADMET Testing Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 South & Central America - PEST Analysis
4.3 Expert Opinion
5. South & Central America Pharma ADMET Testing Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 High Rate of Late-Stage Drug Failure
5.1.2 Increasing Number of Product Approvals and Launches
5.2 Market Restraints
5.2.1 High Cost of ADME Testing Studies
5.3 Market Opportunities
5.3.1 Automation and Advancements in ADME Testing
5.4 Future Trends
5.4.1 The Advent of High-Throughput Screening
5.5 Impact Analysis
6. Pharma ADMET Testing Market- South & Central America Analysis
6.1 South & Central America Pharma ADMET Testing Market Revenue Forecast and Analysis
7. South & Central America Pharma ADMET Testing Market- By Testing Type
7.1 Overview
7.2 South & Central America Pharma ADMET Testing Market, By Testing Type 2022 & 2028 (%)
7.3 In Vivo ADMET Testing
7.3.1 Overview
7.3.2 In Vivo ADMET Testing - Revenue and Forecast to 2028 (US$ Million)
7.4 In Vitro ADMET Testing
7.4.1 Overview
7.4.2 In Vitro ADMET Testing - Revenue and Forecast to 2028 (US$ Million)
7.5 In Silico ADMET Testing
7.5.1 Overview
7.5.2 In Silico ADMET Testing - Revenue and Forecast to 2028 (US$ Million)
8. South & Central America Pharma ADMET Testing Market- By Technology
8.1 Overview
8.2 South & Central America Pharma ADMET Testing Market, By Technology 2022 & 2028 (%)
8.3 Cell Culture
8.3.1 Overview
8.3.2 Cell Culture - Market Revenue and Forecast to 2028 (US$ Million)
8.4 High Throughput
8.4.1 Overview
8.4.2 High Throughput - Market Revenue and Forecast to 2028 (US$ Million)
8.5 Molecular Imaging
8.5.1 Overview
8.5.2 Molecular Imaging - Market Revenue and Forecast to 2028 (US$ Million)
8.6 OMICS Technology
8.6.1 Overview
8.6.2 OMICS Technology - Market Revenue and Forecast to 2028 (US$ Million)
9. South & Central America Pharma ADMET Testing Market- By Application
9.1 Overview
9.2 South & Central America Pharma ADMET Testing Market, By Application 2022 & 2028 (%)
9.3 Systemic Toxicity
9.3.1 Overview
9.3.2 Systemic Toxicity - Market Revenue And Forecasts to 2028 (US$ Million)
9.4 Renal Toxicity
9.4.1 Overview
9.4.2 Renal Toxicity - Market Revenue And Forecasts to 2028 (US$ Million)
9.5 Hepatotoxicity
9.5.1 Overview
9.5.2 Hepatotoxicity - Market Revenue And Forecasts to 2028 (US$ Million)
9.6 Neurotoxicity
9.6.1 Overview
9.6.2 Neurotoxicity - Market Revenue And Forecasts to 2028 (US$ Million)
9.7 Others
9.7.1 Overview
9.7.2 Others - Revenue And Forecasts to 2028 (US$ Million)
10. South & Central America Pharma ADMET Testing Market- Country Analysis
10.1 South & Central America: Pharma ADMET Testing Market
10.1.1 Overview
10.1.2 South and Central America: Pharma ADMET Testing Market, by Country, 2022 & 2028 (%)
10.1.2.1 Brazil: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (USD Million)
10.1.2.1.1 Brazil: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (USD Million)
10.1.2.1.2 Brazil: Pharma ADMET Testing Market, by Testing Type, 2019-2028 (USD Million)
10.1.2.1.3 Brazil: Pharma ADMET Testing Market, by Technology, 2019-2028 (USD Million)
10.1.2.1.4 Brazil: Pharma ADMET Testing Market, by Application, 2019-2028 (USD Million)
10.1.2.2 Argentina: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (USD Million)
10.1.2.2.1 Argentina: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (USD Million)
10.1.2.2.2 Argentina: Pharma ADMET Testing Market, by Testing Type, 2019-2028 (USD Million)
10.1.2.2.3 Argentina: Pharma ADMET Testing Market, by Technology, 2019-2028 (USD Million)
10.1.2.2.4 Argentina: Pharma ADMET Testing Market, by Application, 2019-2028 (USD Million)
10.1.2.3 Rest of South & Central America: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (USD Million)
10.1.2.3.1 Rest of South & Central America: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (USD Million)
10.1.2.3.2 Rest of South & Central America: Pharma ADMET Testing Market, by Testing Type, 2019-2028 (USD Million)
10.1.2.3.3 Rest of South & Central America: Pharma ADMET Testing Market, by Technology, 2019-2028 (USD Million)
10.1.2.3.4 Rest of South & Central America: Pharma ADMET Testing Market, by Application, 2019-2028 (USD Million)
11. South & Central America Pharma ADMET Testing Market-Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. Company Profiles
12.1 Charles River Laboratories
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Promega Corporation
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Sigma-Aldrich (MERCK KGaA)
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Agilent Technologies, Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Biovia (Dassault Systemes)
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Bio-Rad Laboratories, Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 IQVIA Inc.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. South & Central America Pharma ADMET Testing Market -Revenue and Forecast to 2028 (US$ Million)
Table 2. Brazil: Pharma ADMET Testing Market, by Testing Type - Revenue and Forecast to 2028 (USD Million)
Table 3. Brazil: Pharma ADMET Testing Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 4. Brazil: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 5. Argentina: Pharma ADMET Testing Market, by Testing Type - Revenue and Forecast to 2028 (USD Million)
Table 6. Argentina: Pharma ADMET Testing Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 7. Argentina: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 8. Rest of South & Central America: Pharma ADMET Testing Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 9. Rest of South & Central America: Pharma ADMET Testing Market, by Technology - Revenue and Forecast to 2028 (USD Million)
Table 10. Rest of South & Central America: Pharma ADMET Testing Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 11. Organic Developments Done by Companies
Table 12. Inorganic Developments Done by Companies
Table 13. Glossary of Terms
LIST OF FIGURES
Figure 1. South & Central America Pharma ADMET Testing Market Segmentation
Figure 2. South & Central America Pharma ADMET Testing Market, By Country
Figure 3. South & Central America Pharma ADMET Testing Market Overview
Figure 4. In vivo ADMET Testing Segment Held Largest Share of Testing Type Segment in South & Central America Pharma ADMET Testing Market
Figure 5. Brazil is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. South & Central America: PEST Analysis
Figure 7. Expert Opinion
Figure 8. South & Central America Pharma ADMET Testing Market Impact Analysis of Driver and Restraints
Figure 9. South & Central America Pharma ADME Testing Market- Revenue Forecast and Analysis - 2022 - 2028
Figure 10. South & Central America Pharma ADMET Testing Market, by Testing Type 2022 & 2028 (%)
Figure 11. In Vivo ADMET Testing - Revenue and Forecasts to 2028 (US$ Million)
Figure 12. In Vitro ADMET Testing - Revenue and Forecasts to 2028 (US$ Million)
Figure 13. In Silico ADMET Testing - Revenue and Forecasts to 2028 (US$ Million)
Figure 14. South & Central America Pharma ADMET Testing Market, by Technology 2022 & 2028 (%)
Figure 15. Cell Culture - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 16. High Throughput - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 17. Molecular Imaging - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 18. OMICS Technology - Market Revenue and Forecasts to 2028 (US$ Million)
Figure 19. South & Central America Pharma ADMET Testing Market, by Application 2022 & 2028 (%)
Figure 20. Systemic Toxicity - Market Revenue And Forecasts to 2028 (US$ Million)
Figure 21. Renal Toxicity - Market Revenue And Forecasts to 2028 (US$ Million)
Figure 22. Hepatotoxicity - Market Revenue And Forecasts to 2028 (US$ Million)
Figure 23. Neurotoxicity - Market Revenue And Forecasts to 2028 (US$ Million)
Figure 24. Others - Revenue And Forecasts to 2028 (US$ Million)
Figure 25. South & Central America: Pharma ADMET Testing Market, by Key Country - Revenue (2022) (US$' Million)
Figure 26. South and Central America: Pharma ADMET Testing Market, by Country, 2022 & 2028 (%)
Figure 27. Brazil: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (USD Million)
Figure 28. Argentina: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (USD Million)
Figure 29. Rest of South & Central America: Pharma ADMET Testing Market - Revenue and Forecast to 2028 (USD Million)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security